N.V. RYLOVA¹, A.V. ZHOLINSKIY²

¹Kazan State Medical University, Kazan

²Federal Scientific-Clinical Centre of Sports Medicine and Rehabilitation, Moscow

  Contact:

Rylova N.V. ― MD, Professor of the Department of Hospital Pediatrics with a course of Polyclinical Pediatrics

Address: 49 Butlerov Str., Kazan, Russian Federation, 420012, e-mail: rilovanv@mail.ru

There are many evidences that high (optimal) concentrations of 25 (OH) D in blood are associated with lower incidence of diseases and death rates. For some diseases, correction of vitamin D deficit reduces the risk of morbidity and, probably, lethality. For many diseases sensitive to vitamin D, a risk factor is 25 (OH) D concentrations in blood lower than 20 nanogram/ml. The risk can be minimized by taking prophylactic doses of vitamin D. Monitoring of 25 (OH) D concentration is necessary to correct the vitamin D level and achieve optimal concentration of 25 (OH) D.

Key words: vitamin D deficit, 25 (OH) D in blood, prophylaxis of vitamin D hypovitaminosis.

(For citation: Rylova N.V., Zholinskiy A.V. Role of vitamin D in prophylaxis of cardiovascular diseases. Practical medicine. 2020. Vol. 18, №1, P. 50-53)

REFERENCES

1. Pludowski P., Holick M.F., Grant W.B. et al. Vitamin D supplementation guidelines. Steroid Biochem. Mol Biol, 2018, 175, pp. 125-35. https://doi. org/10.1016/j.jsbmb.2017.01.021.
2. McDonnell S.L., Baggerly C., French C.B. et al. Serum 25-Hydroxyvitamin D Concentrations >/=40 ng/ml Are associated with >65% lower cancer risk: pooled analysis of randomized trial and prospective cohort study. PLoS ONE, 2016, 11, p. e0152441. https://doi.org/10.1371/journal. pone.0152441.
3. McDonnell S.L., Baggerly C.A., French C.B. et al. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations >/=60 vs <20 ng/ml (150 vs 50 nmol/L): pooled analysis of two randomized trials and a prospective cohort. PLoS ONE, 2018, 13, p. e0199265. https://doi. org/10.1371/journal.pone.0199265.
4. Manson J.E., Cook N.R., Lee I.M. et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. Engl. J. Med, 2019, 380, pp. 33-44. https://doi. org/10.1056/NEJMoa1809944.
5. Pittas A.G., Dawson-Hughes B., Sheehan P. et al. Vitamin D supplementation and prevention of type 2 diabetes. Engl. J. Med, 2019, 381, pp. 520-30. https://doi. org/10.1056/NEJMoa1900906.
6. Rylova N.V., Mal’tsev S.V., Zholinskiy A.V. The role of vitamin D in the regulation of the immune system. Prakticheskaya meditsina, 2017, no. 5 (106), pp. 10-14 (in Russ.).
7. Mal’tsev S.V., Rylova N.V. Vitamin D and immunity. Prakticheskaya meditsina, 2015, no. 1 (86), pp. 114-120 (in Russ.).
8. Martineau A.R., Jolliffe D.A., Hooper R.L. et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ, 2017, 356, p. i6583. https://doi.org/ 10.1136/bmj.i6583.
9. Mirhosseini N., Vatanparast H., Kimball S.M. The association between serum 25(OH)D status and blood pressure in participants of a community-based program taking vitamin D supplements. Nutrients, 2017, 9, p. E1244. https://doi.org/10.3390/nu9111244.
10. McDonnell S.L., Baggerly K.A., Baggerly C.A., et al. Maternal 25(OH)D concentrations >/=40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center. PLoS ONE, 2017, 12, pp. e0180483. https://doi.org/10.1371/journal.pone. 0180483.
11. Holick M.F. Vitamin D defi N. Engl. J. Med, 2007, 357, pp. 266-81. https://doi.org/10.1056/NEJMra070553.
12. Bilinski K., Boyages S. Evidence of overtesting for vitamin D in Australia: an analysis of 4.5 years of Medicare Benefits Schedule (MBS) data. BMJ Open, 2013;3. https://doi.org/10.1136/bmjopen2013-002955.
13. Rockwell M., Kraak V., Hulver M., Epling J. Clinical management of low vitamin D: a scoping review of physicians’ practices. Nutrients, 2018, 10, p. E493. https://doi.org/10.3390/nu10040493.
14. Vasarhelyi B., Satori A., Olajos F. et al. Low vitamin D levels among patients at Semmelweis University: retrospective analysis during a one-year period. Orv Hetil, 2011, 152, pp. 1272-7. https://doi.org/10.1556/OH.2011.29187.
15. Garland C.F., Kim J.J., Mohr S.B. et al. Meta-analysis of all-cause mortality according to serum 25-hydroxy vitamin D. J. Public Health, 2014, 104, pp. e43-50. https://doi.org/10.2105/AJPH.2014.302034.
16. Grant W.B. An estimate of the global reduction in mortality rates through doubling vitamin D levels. J. Clin. Nutr, 2011, 65, pp. 1016-26. https://doi.org/10.1038/ejcn.2011.68. e-pub ahead of print 2011/07/07.
17. World Health Statistics 2016: Annex B: Tables of health statistics by country, WHO region and globally. Report no: 978 92 4 156526 4. Geneva: World Health Organization; 2016.
18. Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation, 2016, 133, pp. 187-225. https://doi.org/10.1161/CIRCULATIONAHA. 115.018585.
19. Bazzano L.A., He J., Muntner P. et al. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern. Med, 2003, 138, pp. 891-7. https://doi.org/10.7326/0003-4819-138-11200306030-00010.
20. Wang L., Song Y., Manson J.E. et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Cardiovasc. Qual Outcomes, 2012, 5, pp. 819-29. https://doi.org/10.1161/CIRCOUTCOMES. 112.967604.
21. Shi H., Chen H., Zhang Y. et al. 25 Hydroxy vitamin D level, vitamin D intake, and risk of stroke: a dose-response meta-analysis. Nutr, 2019. https://doi.org/10. 1016/j.clnu.2019.08.029.
22. Zhou R., Wang M., Huang H. et al. Lower Vitamin D Status Is Associated With An Increased Risk Of Ischemic Stroke: A Systematic Review And Meta-analysis. Nutrients, 2018, 10, p. E277. https://doi.org/10.3390/nu10030277.
23. Barbarawi M., Kheiri B., Zayed Y. et al. Vitamin D supplementation and cardiovascular disease risks in more than 83000 individuals in 21 randomized clinical trials: a meta-analysis. JAMA Cardiol, 2019. https://doi.org/10. 1001/jamacardio.2019.1870.
24. Grant W.B., Boucher B.J., Bhattoa H.P., Lahore H. Why vitamin D clinical trials should be based on 25-hydroxy vitamin D concentrations. Steroid Biochem. Mol Biol, 2018, 177, pp. 266-9. https:// doi.org/10.1016/j.jsbmb.2017.08.009.
25. Grant W.B., Bhattoa H.P., Boucher B.J. Seasonal variations of U.S. mortality rates: Roles of solar ultraviolet-B doses, vitamin D, gene expression, and infections. Steroid Biochem. Mol Biol, 2017, 173, pp. 5-12. https://doi.org/10.1016/j.jsbmb.2017.01.003.
26. Kroll M.H., Bi C., Garber C.C. et al. Temporal relationship between vitamin D status and parathyroid hormone in the United States. PloS ONE, 2015, 10, p. e0118108. https://doi.org/10.1371/journal.pone.0118108.
27. Amrein K., Papinutti A., Mathew E. et al. Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa. Connect, 2018, 7, pp. R304-15. https://doi. org/10.1530/EC-18-0184.
28. de Haan K., Groeneveld A.B., de Geus H.R. et al. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis. Care, 2014, 18, p. 660. https://doi.org/10.1186/s13054-014-0660-4.
29. Moromizato T., Litonjua A.A., Braun A.B. et al. Association of low serum 25-hydroxy vitamin D level sand sepsis in the critically ill. Crit Care Med, 2014, 42, pp. 97-107. https://doi.org/10.1097/CCM.0b013e31829eb7af.
30. Quraishi S.A., Bittner E.A., Blum L. et al. Prospective study of vitamin D status at initiation of care in critically ill surgical patients and risk of 90-day mortality. Crit Care Med, 2014, 42, pp. 1365-71. https://doi.org/10.1097/ CCM.0000000000000210.
31. Arnson Y., Gringauz I., Itzhaky D., Amital H. Vitamin D deficiency is associated with poor outcomes and increased mortality in severely ill patients. QJM, 2012, 105, pp. 633-9. https://doi.org/10. 1093/qjmed/hcs014.
32. Braun A.B., Gibbons F.K., Litonjua A.A. et al. Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med, 2012, 40, pp. 63-72. https://doi.org/10.1097/CCM.0b013e31822d74f3.
33. Langlois P.L., Szwec C., D’Aragon F. et al. Vitamin D supplementation in the critically ill: a systematic review and meta-analysis. Nutr, 2018, 37, pp. 1238-46. https:// doi.org/10.1016/j.clnu.2017.05.006.
34. Amrein K., Schnedl C., Holl A. et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdALICU randomized clinical trial. JAMA, 2014, 312, pp. 1520-30. https:// doi.org/10.1001/jama.2014.13204.
35. Quraishi S.A., De Pascale G., Needleman J.S. et al. Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: a randomized, placebo-controlled Trial. Crit Care Med, 2015, 43, pp. 1928-37. https://doi.org/10.1097/CCM.0000000000001148.
36. Han J.E., Jones J.L., Tangpricha V. et al. High dose vitamin D administration in ventilated intensive care unit patients: a pilot double blind randomized controlled trial. Clin. Transl. Endocrinol, 2016, 4, pp. 59-65. https://doi.org/10.1016/j. jcte.2016.04.004.
37. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M. et al. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Clin. Endocrinol. Metab, 2011, 96 (7), pp. 1911-30.
38. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A. et al. Controversy in clinical Endocrinology: guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. Clin. Endocrinol. Metab, 2012, 97, pp. 1153-8.
39. IOM (Institute of Medicine) Dietary reference intakes for calcium and vitamin D. Committee to Review Dietary Reference in takes for Calcium and Vitamin D Washington DC: The National Academies Press Institute of Medicine 2011.
40. Karimi K., Lindgren T.H., Koch C.A., Brodell R.T. Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer. Endocr. Metab. Disord, 2016, 17 (3), pp. 389-403.